VANCOUVER --
Researchers say a new drug tested at the University of British Columbia is highly effective against multiple COVID-19 variants.
They say the experimental drug called N-0385, developed at Universite de Sherbrooke in Quebec, blocks the virus that causes COVID-19 from entering human cells through its preferred entry point.
The experimental drug impedes cellular entry of the virus, says Dr. Richard Leduc, project lead at Sherbrooke.
“It’s not a treatment, it’s a protector against the virus," Leduc said, which is why they believe it will work against all variants.
N-0385 doesn’t combat a specific strain of COVID-19. It's designed to block viruses of all kinds from entering the human cell in the first place.